eHI August 10, 2020

This report outlines several key findings, which were developed after convening pharmaceutical manufacturers, health plans, community based SDOH programs, patient advocacy organizations, and other experts. Merck and Boehringer Ingelheim Pharmaceuticals, Inc. participated and provided financial support for development of the report. Findings addressed in the report include:

  • Using COVID-19 as a catalyst for change
  • The role of data in advancing health equity
  • A shared SDOH framework
  • Tools for putting...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Equity/SDOH, Healthcare System, Insurance, Payer, Pharma, Pharma / Biotech, Survey / Study, Trends
Advancing Equitable Access to Elevate Value-Based Cancer Care
Hospices Have Long Road Ahead on Improving Health Equity
Election Implications for Telehealth, Health Equity, AI and Life Sciences
Podcast: Washington Housing Conservancy Shapes Health via Housing Reform
Alzheimer Disease Treatment Can Improve Population Health and Health Equity

Share This Article